Table of Contents
Historical Data, Premium Insights, Market Dynamic, Analysis and Projection, By Product, Analysis and Projection, By Application, Analysis and Projection, By End-Use, Analysis and Projection, By Regional Analysis, Competitive Landscape, Company Profiles, Market Revenue, Sale & Price Analysis
Related Topics
Kitchen Installation Services Market Size Artisan Chocolate Market Size Ketoanalogue for Kidney Disease Market Size Inflammatory Bowel Disease Treatment Market SizeGlobal Cholera Vaccines Market Size to Worth USD 229.4 Million by 2033
According to a research report published by Spherical Insights & Consulting, The Global Cholera Vaccines Market Size is Expected to Grow from USD 94.5 Million in 2023 to USD 229.4 Million by 2033, Growing at a CAGR of 9.27% from 2023 to 2033.
Browse 210 market data Tables and 45 Figures spread through 190 Pages and in-depth TOC on the Global Cholera Vaccines Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Dukoral, Vaxchora, Shanchol, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.
The cholera vaccine industry is involved with companies and organizations that develop, produce, and distribute vaccines to prevent the spread of cholera. Cholera is a bacterial infection that spreads through tainted food and water caused by the bacteria named Vibrio cholerae. It can cause severe diarrhea, abdominal pain, dehydration, and fever. Moreover, the technological advancement in the new vaccine development with their high immunity power and enhanced invention helps to improve the market growth. However, the process of vaccine formation is a time-consuming process that takes more investment for the vaccine formation due to the consideration of properties related to antibiotic alternatives. Additionally, cholera vaccines may have major negative side effects on human health, so because of this, it takes more time to develop a more efficient and resulting vaccine to prevent bacterial infections. Which may hamper the industry growth of cholera vaccines.
The Dukoral segment secured the largest share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the product type, the global cholera vaccine market is classified into Dukoral, Vaxchora, Shanchol, and others. Among these, the Dukoral segment secured the largest share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period. This dominance is attributed to its major usages in endemic regions as well as for traveller immunization. Also, there is an increasing need for these vaccines among poor and middle-income economies across the world boost the segment.
The hospital pharmacy segment accounted for the highest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period.
Based on the distribution channel, the global cholera vaccine market is categorized into hospital pharmacy, retail pharmacy, and others. Among these, the hospital pharmacy segment accounted for the highest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period. This is due to hospitals becoming easier to reach patients at the first moment of symptoms and treat them quickly with skilled doctors and supportive paramedical staff. Further, availability is due to its well-developed storage facilities and integrated patient care system, and implementing preventive measures to manage the cholera outbreak, which propels the segment expansion.
North America is projected to hold the largest share of the global cholera vaccine market over the forecast period.
North America is projected to hold the largest share of the global cholera vaccine market over the forecast period. This region increased awareness among the consumers and strong government policies support for vaccination activities. Also, the high adoption rate of international traveller vaccines, and many people are directed towards being protective before going to see cholera-prone areas. Additionally, the need for immunization to protect tourists and aid workers traveling to cholera-affected areas has been highlighted by the growing concerns about migration and international travel.
Asia-Pacific is expected to grow at the fastest CAGR of the global cholera vaccine market during the forecast period. This is attributed to its increased access to effective preventive measures, rise in public awareness of the disease, and the disease's high incidence rate. Also, the region's high population density, frequent natural disasters, and inadequate sanitation make it extremely vulnerable to cholera outbreaks, which supports substantial investment from regional health care authorities. Further, the support of government officials with the WHO and its related programs opens up wide opportunities for vaccination and other medical terminology.
Company Profiling
Major key players in the cholera vaccine market include Shantha Biotechnics Limited, Valneva SE, Serum Institute of India, Sanofi S.A., Emergent BioSolutions Inc., PaxVax Inc., Hilleman Laboratories, EuBiologics Co., Ltd., Incepta Vaccine Ltd., Astellas Pharma Inc., Bharat Biotech, Biological E., and Others.
Key Target Audience
Recent Development
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global cholera vaccine market based on the below-mentioned segments:
Global Cholera Vaccine Market, By Product Type
Global Cholera Vaccine Market, By Distributional Channels
Global Cholera Vaccine Market, By Regional
May 2025 - The Global Sickle Cell Disease Diagnosis Market Size is Expected to Grow from USD 2.70 Billion in 2023 to USD 11.00 Billion by 2033, at a CAGR of 15.08% during the forecast period 2023-2033.
May 2025 - The Global Rare Disease Genetic Testing Market Size is Expected to Grow from USD 1012.90 Million in 2023 to USD 3788.00 Million by 2033, at a CAGR of 14.10% during the forecast period 2023-2033.
May 2025 - The Global Rare Dermatological Disease Treatment Market Size is Expected to Grow from USD 6.78 Billion in 2023 to USD 11.04 Billion by 2033, at a CAGR of 5.00% during the forecast period 2023-2033.
We have received your message and would like to thank you for writing to us. If your inquiry is urgent, please use the telephone number listed below to talk to one of our staff members. Otherwise, we will reply by email as soon as possible.
+1 303 800 4326 +91 9561448932 emailsales@sphericalinsights.com
